Share Issue/Capital Change • Feb 5, 2021
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 1543O
Assura PLC
05 February 2021
5 February 2021
Assura plc
Additional Listing
Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that 167,681 New Ordinary Shares (the "New Shares") have been issued to the Assura plc Employee Benefit Trust in order to satisfy the awards pursuant to the 2017 Performance Share Plan.
Application has therefore been made for the admission of the New Shares to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities ("Admission"). The New Shares will rank pari passu with the Company's existing ordinary shares and Admission is expected to occur at 8.00am on 8 February 2021.
Following the allotment of the New Shares, it is expected that the total number of shares in issue will be 2,671,853,938 (none of which will be held in treasury) and that, accordingly, the total number of voting rights of the Company will be 2,671,853,938.
For more information, please contact:
| Assura plc Orla Ball, Company Secretary David Purcell, Head of Investor Relations |
Tel: 01925 420660 Email: [email protected] |
| Finsbury Gordon Simpson James Thompson |
Tel: 0207 251 3801 Email: [email protected] |
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association.
Assura plc LEI code: 21380026T19N2Y52XF72
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ALSUPUQGPUPGUBA
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.